S-(2-carboxy-1-(1H-imidazol-4-yl) ethyl)cysteine: precursor of 3-((carboxymethyl)thio)-2-(1H-imidazol-4-yl)propanoic acid; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 126110 |
MeSH ID | M0188491 |
Synonym |
---|
beta-((2-amino-2-carboxyethyl)thio)-1h-imdiazole-4-propanoic acid |
s-(2-carboxy-1-(1h-imidazol-4-yl) ethyl)cysteine |
134381-43-4 |
1h-imdiazole-4-propanoic acid, beta-((2-amino-2-carboxyethyl)thio)- |
2-diecys |
3-[-(2-amino-2-carboxyethyl)thio]-3-(1h-imidazol-4-yl)propanoic acid |
DTXSID00928593 |
s-[2-carboxy-1-(1h-imidazol-5-yl)ethyl]cysteine |
3-(2-amino-2-carboxyethyl)sulfanyl-3-(1h-imidazol-5-yl)propanoic acid |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |